US FDA Employs Familiar Strategy In Ending Novo’s Wegovy, Ozempic Shortage

 
• By Sue Sutter
  
Empty shelves
The FDA said the shortage of Novo Nordisk's Wegovy and Ozempic is over. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Distribution/Supply Chain

More from Legal & IP